You are being redirected to the story the piece of content is found in so you can read it in context. Please click the following link if you are not automatically redirected within a couple seconds:

New Report: Top pharma companies fail to address industry best practices on HIV/AIDS

Author: Interfaith Center on Corporate Responsibility [USA], Published on: 14 August 2006

The Interfaith Center on Corporate Responsibility released a comprehensive scorecard evaluating the pharmaceutical industry's efforts in the fight against HIV/AIDS...The ICCR report highlights the large disparities between industry best practices in addressing...HIV/AIDS...and the current actions of 15 leading pharmaceutical companies. "We see two major problems - a failure to develop new medicines that address neglected diseases and a lack of access for poor patients to the existing medicines," said Daniel Rosan, ICCR's Program Director for Public Health and author of the report... [companies rated: Abbott Laboratories, AstraZeneca, Boehringer-Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Gilead Sciences, Johnson & Johnson, Eli Lilly, Merck, Novartis, Pfizer, Hoffmann-La Roche (part of Roche), sanofi-aventis, Schering-Plough, Wyeth]

Read the full post here

Related companies: Abbott Laboratories AstraZeneca Boehringer Ingelheim Bristol-Myers Squibb Eli Lilly Gilead Sciences GlaxoSmithKline Hoffmann-La Roche (part of Roche) Johnson & Johnson Merck Novartis Pfizer Roche Sanofi Schering-Plough Wyeth (part of Pfizer)